Capital Advisors Ltd’s IGM Biosciences IGMS Stock Holding History

Capital Advisors Ltd’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-776	Closed	-$1K	–	1452
2025 Q2	$1K	Buy	776 +518	+201%	+$633	﹤0.01%	1202
2025 Q1	$0	Buy	+258	New	+$480	﹤0.01%	1448

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Capital Advisors Ltd's IGMS Position: Q3 2025 in Review

Capital Advisors Ltd sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 776 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in IGMS in Q1 2025 and held it in 2 quarters. The position peaked at $1K in Q2 2025. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Capital Advisors Ltd reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Capital Advisors Ltd sold 776 IGM Biosciences shares in Q3 2025, an estimated $1K.
Capital Advisors Ltd first reported a position in IGM Biosciences in Q1 2025 and held it in 2 quarters.
Capital Advisors Ltd's IGM Biosciences position peaked at $1K in Q2 2025.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Capital Advisors Ltd's 13F filing for Q3 2025, filed 16 Oct 2025.